Mrs. Lauren Loop | Allergy and Immunology | Best Researcher Award

 Research

 Investigator Initiated Studies

Multidisciplinary Atopic Dermatitis Program Rady Children’s Hospital San Diego Role: Education/Quality Improvement Director Optimizing Clinical Application of Lymphocyte Activation Tests for the Detection of Causative Medications in Severe Cutaneous Adverse ReactionsRole: Research Coordinator Pilot Study of Air Filtration’s Impact on Clinical Outcomes of Allergic Rhinitis Role: Research Coordinator Collaborative Multi-site Project to Speed the Identification and Management of Rare Immune Diseases Role: Research Coordinator Tracking the Effects of IL-4 and IL-13 on T cells in Human Asthma, Atopic Dermatitis, and Eosinophilic Esophagitis by Lineage Tracing Role: Grants Director/Lead Coordinator Functional Immune Dysregulation in Pediatric Solid Organ Transplant Recipients Role: Research Coordinator Impact of Inhaled Corticosteroids and Biologic Therapy for Moderate to Severe Asthma on Body Mass Index in Children Role: Grants Director Severe Asthma Program Rady Children’s Hospital San Diego Role: Data Analyst/Patient Educator Correlating Changes in Skin Clearance/Clinician Reported Outcomes with Patient Reported Outcome Measures in Atopic Dermatitis Role: Grants Director Real World Experience and Pharmacokinetics of IG-Naïve Immunodeficiency Patients Starting Cuvitru Role: Grants Director Use of Tezepelumab for CVID Type 2 Inflammatory Disease Role: Grants Director Assessing Quality of Life and Clinical Improvement of Antibody Deficiency Patients with Chronic Lung Disease Refractory to Conventional IG Replacement Therapy on Asceniv Role: Grants Director A Quality Improvement Study – Assessing Total Steroid Burden for Patient with Atopic Dermatitis Role: Grants Director Characterization of Unmet Need for Targeted Precision Medication in Atopic Dermatitis Due to Inadequate or Poor Response to Dupilumab Role: Grants Director

 Sponsored Studies

Registry Study of Revcovi Treatment in Patients With ADA-SCID Role: Rare Disease Director,  A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients with Hereditary Angioedema (HAE) Role: Rare Disease Director, Efficacy and Safety Study of Mavorixafor in Participants with Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome Role: Research Coordinator,  Preventing Asthma in High-Risk Kids (PARK) Role: Research Coordinator